Mass. Movers

Heart device maker slumps as profit falls

Abiomed’s AbioCor Total Replacement Heart.
Abiomed’s AbioCor Total Replacement Heart.

Shares of the medical device maker Abiomed Inc. fell sharply after the Danvers company reported lower profit in the third quarter, despite posting strong sales growth. Abiomed reported third-quarter fiscal 2013 revenue of $38.3 million, up 19 percent, compared to $32.2 million in fiscal 2012, on record quarterly patient product usage. Abiomed also reported net income of $2.7 million, or 7 cents a share, compared to net income of $2.9 million, 7 cents, in fiscal 2012.